Annual Accounts Receivable
$121.80 M
+$48.41 M+65.96%
December 1, 2024
Summary
- As of March 12, 2025, RARE annual accounts receivable is $121.80 million, with the most recent change of +$48.41 million (+65.96%) on December 1, 2024.
- During the last 3 years, RARE annual accounts receivable has risen by +$93.37 million (+328.39%).
- RARE annual accounts receivable is now at all-time high.
Performance
RARE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$121.80 M
+$28.50 M+30.55%
December 1, 2024
Summary
- As of March 12, 2025, RARE quarterly accounts receivable is $121.80 million, with the most recent change of +$28.50 million (+30.55%) on December 1, 2024.
- Over the past year, RARE quarterly accounts receivable has increased by +$48.41 million (+65.96%).
- RARE quarterly accounts receivable is now at all-time high.
Performance
RARE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RARE Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +66.0% | +66.0% |
| 3 y3 years | +328.4% | +328.4% |
| 5 y5 years | +270.9% | +270.9% |
RARE Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +328.4% | at high | +329.4% |
| 5 y | 5-year | at high | +427.4% | at high | +717.8% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Ultragenyx Pharmaceutical Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $121.80 M(+66.0%) | $121.80 M(+30.5%) |
| Sep 2024 | - | $93.30 M(-12.0%) |
| Jun 2024 | - | $105.98 M(+5.7%) |
| Mar 2024 | - | $100.25 M(+36.6%) |
| Dec 2023 | $73.39 M(+81.5%) | $73.39 M(-7.4%) |
| Sep 2023 | - | $79.26 M(+12.4%) |
| Jun 2023 | - | $70.52 M(+64.0%) |
| Mar 2023 | - | $42.99 M(+6.3%) |
| Dec 2022 | $40.45 M(+42.3%) | $40.45 M(+29.8%) |
| Sep 2022 | - | $31.16 M(-16.2%) |
| Jun 2022 | - | $37.21 M(+31.2%) |
| Mar 2022 | - | $28.37 M(-0.2%) |
| Dec 2021 | $28.43 M | $28.43 M(+12.0%) |
| Sep 2021 | - | $25.38 M(+2.7%) |
| Jun 2021 | - | $24.72 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $25.03 M(+8.4%) |
| Dec 2020 | $23.09 M(-29.7%) | $23.09 M(-16.8%) |
| Sep 2020 | - | $27.76 M(+86.4%) |
| Jun 2020 | - | $14.89 M(-49.2%) |
| Mar 2020 | - | $29.33 M(-10.7%) |
| Dec 2019 | $32.84 M(+157.8%) | $32.84 M(+42.1%) |
| Sep 2019 | - | $23.12 M(+10.6%) |
| Jun 2019 | - | $20.90 M(+33.7%) |
| Mar 2019 | - | $15.63 M(+22.7%) |
| Dec 2018 | $12.74 M(+146.3%) | $12.74 M(+39.2%) |
| Sep 2018 | - | $9.15 M(-47.5%) |
| Jun 2018 | - | $17.43 M(+374.7%) |
| Mar 2018 | - | $3.67 M(-29.0%) |
| Dec 2017 | $5.17 M(>+9900.0%) | $5.17 M(>+9900.0%) |
| Dec 2016 | $0.00 | $0.00(-100.0%) |
| Sep 2013 | - | $38.00 K |
FAQ
- What is Ultragenyx Pharmaceutical annual accounts receivable?
- What is the all time high annual accounts receivable for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual accounts receivable year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly accounts receivable year-on-year change?
What is Ultragenyx Pharmaceutical annual accounts receivable?
The current annual accounts receivable of RARE is $121.80 M
What is the all time high annual accounts receivable for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual accounts receivable is $121.80 M
What is Ultragenyx Pharmaceutical annual accounts receivable year-on-year change?
Over the past year, RARE annual accounts receivable has changed by +$48.41 M (+65.96%)
What is Ultragenyx Pharmaceutical quarterly accounts receivable?
The current quarterly accounts receivable of RARE is $121.80 M
What is the all time high quarterly accounts receivable for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly accounts receivable is $121.80 M
What is Ultragenyx Pharmaceutical quarterly accounts receivable year-on-year change?
Over the past year, RARE quarterly accounts receivable has changed by +$48.41 M (+65.96%)